BACTERIAL VAGINOSIS ASSOCIATED WITH ATOPOBIUM VAGINAE: THE CURRENT PRINCIPLES OF DIAGNOSIS AND THERAPY


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Objective. To optimize therapy for bacterial vaginosis associated with Atopobium vaginae (A. vaginae). Subjects and methods. The study enrolled 60 women who received therapy with one of the drugs (metronidazole gel, 0.75%, clindamycin cream 2%, hexicon suppositories). To evaluate the efficiency of therapy, the authors made a clinical laboratory examination, assessed the symptoms of bacterial vaginosis according the Amsel criteria, estimated the lactobacillus component of the vaginal microflora, and identified A. vaginae. Results. Therapy with vaginal hexicon suppositories demonstrated a high clinical laboratory efficiency (95%) that was comparable with that of clindamycin and greater than that of metronidazole.

Толық мәтін

Рұқсат жабық

Авторлар туралы

M. RAKHMATULINA

State Dermatovenereology Research Center, Ministry of Health and Social Development of Russia

Email: rahmatulina@cnikvi.ru
Moscow

K. PLATOVA

State Dermatovenereology Research Center, Ministry of Health and Social Development of Russia

Moscow

Әдебиет тізімі

  1. Прилепская В.Н. Инфекции в гинекологии. Особенности инфекционных процессов нижнего отдела половых путей. Возможности терапии препаратами для локального применения // Гинекология. - 2000. - Т. 2, № 2. -С. 41-46.
  2. Bradshaw C.S., Tabrizi S.N., Fairley C.K. et al. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy // J. Infect. Dis. - 2006. - Vol. 194, № 6. - P. 828-836.
  3. Chaudhuri M., Chatterjee B.D. Pathogenic potential of Gardnerella vaginalis on the female urogenital system // J. Indian Med. Assoc. - 1996. - Vol. 94, № 1. - P. 11-13.
  4. Collins M.D., Walbanks S. Comparative sequence analysis of the 16 S rRNA genes of Lactobacillus miuitus, Lactobacillus rimae and Streptococcus parvulus: proposal for the creation of a new genus Atopobium // FEMS Microbiol. Lett. - 1992. -№ 95. - P. 235-240.
  5. De Backer E., Verhelst R., Verstraelen H. et al. Antibiotic susceptibility of Atopobium vaginae // BMC Infect. Dis. -2006. - Vol. 6, № 1. - P. 51.
  6. Eibdörfer W., Böhmer C., Pelz K. et al. Tuboovarian abscess caused by Atopobium vaginae following transvaginal oocyte recovery // J. Clin. Microbiol. - 2003. - Vol. 41, № 6. -P. 2788-2790.
  7. Ferris M.J., Masztal A., Aldridge K.E. et al. Association of Atopobium vaginae, a recently described metronidazole resistant anaerobe, with bacterial vaginosis // BMC Infect. Dis. - 2004. - № 4. - P. 5-13.
  8. Ferris M.J., Norori N., Zozaya-Hinchliffe M., Martin D.H. Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment // J. Clin. Microbiol. - 2007. - Vol. 45, № 3. - P. 1016-1018.
  9. Fredricks D.N., Fiedler T.L., Marrazzo J.M. Molecular identification of bacteria associated with bacterial vaginosis // N. Engl. J. Med. - 2005. - № 353. - P. 1899-1911.
  10. Jovita M.R., Collins M.D., Sjoden B., Falsen E. Characterization of a novel Atopobium isolate form the human vagina description of Atopobium vaginae sp. nov. // Int. J. Syst. Bacteriol. - 1999. - № 49. - P. 1573-1576.
  11. Theron M.M., Janse Van Rensburg M.N., Chalkley L.J. Nitroimidazole resistance genes (nimB) in anaerobic Grampositive cocci (previously Peptotreptococcus spp.) // J. Antimicrob. Chemother. - 2004. - № 54. - P. 240-242.
  12. Zhou X., Bent S.J., Schneider M.G. et al. Is Atopobium vaginae a predominant member in vaginal microbial communities of healthy women // ASM General Meeting, Washington DC, 18-22 May, 2003.
  13. Zhou X., Bent S.J., Schneider M.G. et al. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods // BMC Microbiology. - 2004. - № 150. - P. 2565-2573.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>